BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 10702891)

  • 21. Comparison of the inhibitory effects of cilostazol, acetylsalicylic acid and ticlopidine on platelet functions ex vivo. Randomized, double-blind cross-over study.
    Ikeda Y; Kikuchi M; Murakami H; Satoh K; Murata M; Watanabe K; Ando Y
    Arzneimittelforschung; 1987 May; 37(5):563-6. PubMed ID: 2956957
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect on platelet function of cilostazol, clopidogrel, and aspirin, each alone or in combination.
    Comerota AJ
    Atheroscler Suppl; 2005 Dec; 6(4):13-9. PubMed ID: 16275168
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pharmacodynamic interaction studies of Ginkgo biloba with cilostazol and clopidogrel in healthy human subjects.
    Aruna D; Naidu MU
    Br J Clin Pharmacol; 2007 Mar; 63(3):333-8. PubMed ID: 17010102
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pharmacokinetics and pharmacodynamics of the antiplatelet combination aspirin (acetylsalicylic acid) plus extended-release dipyridamole are not altered by coadministration with the potent CYP2C19 inhibitor omeprazole.
    Offman E; Schobelock MJ; Brickl R; VanderMaelen CP; Ehrlich J; Eisert W
    Am J Cardiovasc Drugs; 2013 Apr; 13(2):113-20. PubMed ID: 23532686
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Inhibition of platelet aggregation by combined therapy with aspirin and cilostazol after off-pump coronary artery bypass surgery.
    Onoda K; Ohashi K; Hashimoto A; Okuda M; Shimono T; Nishikawa M; Shimpo H
    Ann Thorac Cardiovasc Surg; 2008 Aug; 14(4):230-7. PubMed ID: 18818572
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of aspirin, carprofen, deracoxib, and meloxicam on platelet function and systemic prostaglandin concentrations in healthy dogs.
    Blois SL; Allen DG; Wood RD; Conlon PD
    Am J Vet Res; 2010 Mar; 71(3):349-58. PubMed ID: 20187838
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of hepatic impairment on the pharmacokinetics of a single dose of cilostazol.
    Bramer SL; Forbes WP
    Clin Pharmacokinet; 1999; 37 Suppl 2():25-32. PubMed ID: 10702884
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparison of the effects of acetylsalicylic acid, ticlopidine and cilostazol on primary hemostasis using a quantitative bleeding time test apparatus.
    Tamai Y; Takami H; Nakahata R; Ono F; Munakata A
    Haemostasis; 1999; 29(5):269-76. PubMed ID: 10754379
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pharmacokinetics and pharmacodynamics of melagatran, the active form of the oral direct thrombin inhibitor ximelagatran, are not influenced by acetylsalicylic acid.
    Fager G; Cullberg M; Eriksson-Lepkowska M; Frison L; Eriksson UG
    Eur J Clin Pharmacol; 2003 Aug; 59(4):283-9. PubMed ID: 12845508
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Ginkgo biloba extract enhances antiplatelet and antithrombotic effects of cilostazol without prolongation of bleeding time.
    Ryu KH; Han HY; Lee SY; Jeon SD; Im GJ; Lee BY; Kim K; Lim KM; Chung JH
    Thromb Res; 2009 Jul; 124(3):328-34. PubMed ID: 19349067
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pharmacokinetics and pharmacodynamics of sibrafiban, an orally administered GP IIb/IIIa antagonist, following coadministration of aspirin and heparin.
    Reimann JD; Modi NB; Novotny W
    J Clin Pharmacol; 2000 May; 40(5):488-95. PubMed ID: 10806602
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Lack of effect of multiple doses of vortioxetine on the pharmacokinetics and pharmacodynamics of aspirin and warfarin.
    Chen G; Zhang W; Serenko M
    J Clin Pharmacol; 2015 Jun; 55(6):671-9. PubMed ID: 25641606
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Does Ginkgo biloba special extract EGb 761 provide additional effects on coagulation and bleeding when added to acetylsalicylic acid 500 mg daily?
    Wolf HR
    Drugs R D; 2006; 7(3):163-72. PubMed ID: 16752942
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Impact of adjunctive cilostazol therapy on platelet function profiles in patients with and without diabetes mellitus on aspirin and clopidogrel therapy.
    Angiolillo DJ; Capranzano P; Ferreiro JL; Ueno M; Capodanno D; Dharmashankar K; Darlington A; Sumner S; Desai B; Charlton RK; Box LC; Zenni M; Guzman LA; Bass TA
    Thromb Haemost; 2011 Aug; 106(2):253-62. PubMed ID: 21614414
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A new cyclooxygenase-2 inhibitor, rofecoxib (VIOXX), did not alter the antiplatelet effects of low-dose aspirin in healthy volunteers.
    Greenberg HE; Gottesdiener K; Huntington M; Wong P; Larson P; Wildonger L; Gillen L; Dorval E; Waldman SA
    J Clin Pharmacol; 2000 Dec; 40(12 Pt 2):1509-15. PubMed ID: 11185674
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A randomized, double-blind, placebo- controlled study on the anti-haemostatic effects of Curcuma longa, Angelica sinensis and Panax ginseng.
    Fung FY; Wong WH; Ang SK; Koh HL; Kun MC; Lee LH; Li X; Ng HJ; Tan CW; Zhao Y; Linn YC
    Phytomedicine; 2017 Aug; 32():88-96. PubMed ID: 28732813
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A comparison of the effects of aspirin on bleeding time measured using the Simplate method and closure time measured using the PFA-100, in healthy volunteers.
    Marshall PW; Williams AJ; Dixon RM; Growcott JW; Warburton S; Armstrong J; Moores J
    Br J Clin Pharmacol; 1997 Aug; 44(2):151-5. PubMed ID: 9278200
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Antiaggregatory effect of oral cilostazol and recovery of platelet aggregability in patients with cerebrovascular disease.
    Yasunaga K; Mase K
    Arzneimittelforschung; 1985; 35(7A):1189-92. PubMed ID: 4074432
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of meloxicam on platelet function in healthy adults: a randomized, double-blind, placebo-controlled trial.
    Rinder HM; Tracey JB; Souhrada M; Wang C; Gagnier RP; Wood CC
    J Clin Pharmacol; 2002 Aug; 42(8):881-6. PubMed ID: 12162470
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pharmacodynamic effects of adjunctive cilostazol therapy in patients with coronary artery disease on dual antiplatelet therapy: impact of high on-treatment platelet reactivity and diabetes mellitus status.
    Capranzano P; Ferreiro JL; Ueno M; Capodanno D; Dharmashankar K; Darlington A; Desai B; Tello-Montoliu A; Rollini F; Angiolillo DJ
    Catheter Cardiovasc Interv; 2013 Jan; 81(1):42-9. PubMed ID: 22431415
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.